Biocon informs about company updates

17 Dec 2018 Evaluate

Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, Biocon has informed about the company statement that the U.S. FDA conducted a GMP inspection of our APIs manufacturing facility at Telangana from December 12- December 14, 2018. The inspection concluded without any observations and no Form 483 was issued. The successful inspection of this site reflects the company's strong commitment to quality and cGMP compliance.

The above information is a part of company's filings submitted to BSE.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×